Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial.
Journal: Nature medicine
Published: July 21, 2023
Efficacy and safety of rademikibart (CBP-201), a next-generation mAb targeting IL-4Rα, in adults with moderate to severe atopic dermatitis: A phase 2 randomized trial (CBP-201-WW001).
Journal: The Journal of allergy and clinical immunology
Published: June 06, 2023
Showing 1-2 of 2
Last Updated: 09/26/2026